Haematocrit

Haematocrit (Hct) is the proportion of your blood made up of red blood cells, expressed as a percentage. Because red blood cells transport oxygen to every tissue, haematocrit is one of the clearest indicators of how effectively your body can deliver oxygen where it’s needed. A higher haematocrit means a larger share of your blood volume is red blood cells, while a lower haematocrit means there are fewer of them relative to plasma (the liquid part of blood).

Several factors influence this balance. When red blood cell production drops—due to nutrient deficiencies like iron, vitamin B12, or folate—haematocrit decreases. It can also fall when plasma volume expands, such as during pregnancy or with high fluid intake. On the other hand, haematocrit rises when red blood cell mass increases (for example, with testosterone use, chronic low oxygen levels, or smoking) or when plasma volume decreases due to dehydration.

Because haematocrit responds to both red cell production and hydration status, it is always interpreted alongside related markers such as haemoglobin, red blood cell count, ferritin, iron studies, B12, folate, kidney function, and sometimes erythropoietin. Together, these markers help determine whether haematocrit changes are due to nutrient deficiency, hormonal influences, inflammation, oxygen exposure (e.g., altitude), or lifestyle factors. Understanding your haematocrit provides valuable insight into your energy levels, cardiovascular health, and overall blood oxygenation.

Haematocrit is a key indicator of oxygen delivery and overall metabolic function. When haematocrit is too low, the body struggles to carry enough oxygen to the brain, muscles, and organs. This can result in fatigue, breathlessness, dizziness, brain fog, reduced exercise capacity, headaches, and even heart strain as the body works harder to circulate blood. Low haematocrit commonly results from iron deficiency, vitamin B12 or folate deficiency, chronic kidney disease (which reduces erythropoietin production), long-standing inflammation, or ongoing blood loss. Because these conditions affect nutrient absorption, oxygen transport, and red blood cell formation, haematocrit is a powerful early signal that something in the oxygen-delivery system may need attention.

High haematocrit, however, brings its own risks. When haematocrit is too high, blood becomes thicker and more viscous, making it harder to circulate. This can slow blood flow, increase strain on the heart, and elevate the risk of clot-related events such as deep vein thrombosis. Large cohort studies show a U-shaped relationship: both low and high haematocrit levels are associated with increased mortality. High haematocrit may develop in response to smoking, chronic lung disease, sleep apnoea, dehydration, altitude exposure, testosterone therapy, or conditions that stimulate excess red blood cell production.

Haematocrit also plays a role in vascular health. Research shows that when haematocrit is outside the mid-range—either too low or too high—it can impair endothelial function (the ability of blood vessels to relax and respond appropriately), which contributes to cardiovascular strain. For this reason, maintaining haematocrit in a stable, mid-range zone is generally considered optimal.

From a functional-medicine perspective, haematocrit is a window into how well the body is nourished (iron, B12, folate), oxygenated (sleep quality, lung function, altitude), hydrated, and hormonally regulated. It interacts closely with lifestyle factors such as smoking, sauna use, hydration status, sleep habits, and exercise load. Tracking haematocrit over time helps assess whether interventions—like iron supplementation, smoking cessation, managing sleep apnoea, or optimising hydration—are working. Because haematocrit reflects both red cell mass and plasma volume, it also helps distinguish between true changes in oxygen-carrying capacity and temporary shifts caused by dehydration or fluid retention.

Dietary factors

Diet affects haematocrit primarily through its impact on red blood cell production. Low intake or poor absorption of iron, vitamin B12, or folate reduces red blood cell formation and lowers haematocrit. Examples include diets low in iron-rich foods (red meat, sardines, legumes, leafy greens), low in B12 (common in vegan diets without supplementation), or low in folate (leafy greens, legumes, fortified grains). Chronic under-eating or very low-calorie diets may also suppress red blood cell production.

Lifestyle factors

Smoking and nicotine vaping increase haematocrit by reducing oxygen availability and stimulating red blood cell production. Sleep apnoea raises haematocrit through repeated nighttime drops in oxygen, while treating sleep apnoea (for example, using CPAP) can lower it by about one percentage point on average. Dehydration temporarily increases haematocrit by reducing plasma volume. Regular sauna use and heat exposure may modestly reduce haematocrit by expanding plasma volume.

Related biomarkers

Haematocrit is directly linked to haemoglobin, red blood cell count, and ferritin. Low ferritin or low haemoglobin commonly results in low haematocrit. Kidney function markers (creatinine, eGFR) matter because kidneys regulate erythropoietin, a hormone essential for red blood cell production. Elevated testosterone can also increase haematocrit.

Environmental influences

Altitude increases haematocrit because the body adapts to lower oxygen by producing more red blood cells. Seasonal variation, temperature changes, and high-intensity endurance training can also shift plasma volume and influence haematocrit results.

If your results are high

Diet

Focus on foods that support balanced inflammation and hydration:

• Include 2–3 litres of water per day unless otherwise advised.

• Prioritise hydrating foods (cucumber, citrus, berries, melons).

• Maintain a balanced diet rich in vegetables, legumes, nuts, and omega-3-rich foods such as 2–3 servings of fatty fish weekly.

• Limit excessive alcohol and high-salt foods that may affect fluid balance.

Lifestyle

• Stop smoking or vaping; haematocrit typically decreases gradually after cessation.

• If you snore, wake unrefreshed, or have daytime fatigue, discuss screening for sleep apnoea.

• Maintain regular movement such as 30–45 minutes of walking, cycling, or swimming most days.

• Heat exposure (e.g., sauna use) may help expand plasma volume and mildly reduce haematocrit.

Supplements

• Avoid unsupervised use of testosterone or erythropoietin-stimulating supplements.

• Omega-3 supplements may support vascular health if your clinician recommends them.

Additional tests to consider

• Ferritin, iron studies, B12, folate

• Kidney function (creatinine, eGFR)

• Sleep study if symptoms suggest apnoea

• Testosterone level if clinically relevant

If your results are low

Diet

Support red blood cell production with nutrient-dense foods:

• Include iron-rich foods such as lean red meat 1–2 times per week, sardines, lentils, beans, tofu, pumpkin seeds, and spinach.

• Pair plant-based iron with vitamin C (citrus, capsicum) to boost absorption.

• Add folate-rich foods (leafy greens, legumes, avocado) and B12 sources (fish, eggs, dairy, fortified plant milks if plant-based).

• Ensure adequate protein intake to support red blood cell formation.

Lifestyle

• Maintain moderate, regular exercise to support circulation and oxygen use.

• Support gut health through fibre-rich foods if malabsorption is suspected.

Supplements

Only where indicated:

• Iron, vitamin B12, or folate supplementation may be recommended based on deficiency testing.

• Use supplements under supervision, as excessive iron can be harmful.

Additional tests to consider

• Ferritin, transferrin saturation, serum iron

• Vitamin B12 and folate

• Kidney function

• Screening for blood loss if levels remain low

1. Hematocrit test. (n.d.). MedlinePlus. National Library of Medicine. https://medlineplus.gov/lab-tests/hematocrit-test/

2. Eisenga, M. F., Kieneker, L. M., Touw, D. J., et al. (2018). Active smoking and hematocrit and fasting circulating erythropoietin concentrations in the general population. Mayo Clinic Proceedings, 93(3), 337–343. https://doi.org/10.1016/j.mayocp.2018.01.005

3. Choi, J. B., Loredo, J. S., Norman, D., et al. (2006). Does obstructive sleep apnea increase hematocrit? Sleep & Breathing, 10(3), 155–160. https://doi.org/10.1007/s11325-006-0064-z

4. Heinrich, E. C., Orr, J. E., Gilbertson, D., et al. (2020). Relationships between chemoreflex responses, sleep quality, and hematocrit in Andean men and women. Frontiers in Physiology, 11, 437. https://doi.org/10.3389/fphys.2020.00437

5. Demircioğlu, S., Tekinalp, A., Korkmaz, C., Alkan Baylan, F., & Merter, M. (2025). Changes in body composition and their association with erythrocyte mass in regular exercisers: A cross-sectional study. Medicine, 104(33), e44065. https://doi.org/10.1097/MD.0000000000044065

6. Thirup, P. (2003). Haematocrit: Within-subject and seasonal variation. Sports Medicine, 33(3), 231–243. https://doi.org/10.2165/00007256-200333030-00005

7. Collins, A. J., Ma, J. Z., & Ebben, J. (2000). Impact of hematocrit on morbidity and mortality. Seminars in Nephrology, 20(4), 345–349.

8. Boffetta, P., Islami, F., Vedanthan, R., et al. (2013). A U-shaped relationship between haematocrit and mortality in a large prospective cohort study. International Journal of Epidemiology, 42(2), 601–615. https://doi.org/10.1093/ije/dyt013

9. Martin, M., Nader, E., Rezigue, H., et al. (2025). Impact of hematocrit on coagulation measured by rotational thromboelastometry in healthy subjects and patients with polycythemia. Seminars in Thrombosis and Hemostasis. https://doi.org/10.1055/a-2570-4455

10. Kishimoto, S., Maruhashi, T., Kajikawa, M., et al. (2020). Hematocrit, hemoglobin and red blood cells are associated with vascular function and vascular structure in men. Scientific Reports, 10(1), 11467. https://doi.org/10.1038/s41598-020-68319-1